Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-02-11
DOI
10.3389/fgene.2015.00035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases
- (2015) Maria A.V. Willrich et al. Translational Research
- Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis
- (2014) Daniela S. Ardelean et al. ANGIOGENESIS
- VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2
- (2014) Chul Han et al. ANGIOGENESIS
- Common and Distinctive Pathogenetic Features of Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia 1 and Hereditary Hemorrhagic Telangiectasia 2 Animal Models—Brief Report
- (2014) Eva M. Garrido-Martin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Efficacy of Oral Tacrolimus in Patients with Moderate/Severe Ulcerative Colitis not Receiving Concomitant Corticosteroid Therapy
- (2014) Takuya Inoue et al. INTERNAL MEDICINE
- ELLIPSE Study
- (2014) Sophie Dupuis-Girod et al. mAbs
- Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia
- (2014) Eun-Jung Choi et al. PLoS One
- Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression
- (2014) Simon Tual-Chalot et al. PLoS One
- Update on the clinical utility of once-daily tacrolimus in the management of transplantation
- (2014) Maria Posadas Salas et al. Drug Design Development and Therapy
- Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment
- (2013) Daniela S. Ardelean et al. ANGIOGENESIS
- Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147
- (2013) W. Xie et al. BRITISH JOURNAL OF DERMATOLOGY
- Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
- (2013) Efstathios T Pavlidis WORLD JOURNAL OF GASTROENTEROLOGY
- Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
- (2012) Sophie Dupuis-Girod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide
- (2012) Massimo Franchini et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia
- (2012) Virginia Albiñana et al. THROMBOSIS AND HAEMOSTASIS
- Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohn's Disease
- (2011) Sergio Rutella et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia
- (2011) Scott E. Olitsky AMERICAN JOURNAL OF OTOLARYNGOLOGY
- Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress
- (2011) Mirjana Jerkic et al. CARDIOVASCULAR RESEARCH
- Long-Term Therapy With Thalidomide in Hereditary Hemorrhagic Telangiectasia: Case Report and Literature Review
- (2011) Chih-Hsuan Chen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor- 1 Signaling in Endothelial Cells
- (2011) V. Albinana et al. MOLECULAR PHARMACOLOGY
- The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus
- (2011) Sharareh Siamakpour-Reihani et al. PLoS One
- A Case of Hereditary Hemorrhagic Telangiectasia Associated With Crohn's Disease Successfully Treated With Infliximab
- (2010) Alfredo Papa et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The physiological role of endoglin in the cardiovascular system
- (2010) José M. López-Novoa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
- (2010) C.H. Storch et al. BRITISH JOURNAL OF DERMATOLOGY
- Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia
- (2010) Suppressa Patrizia et al. BRITISH JOURNAL OF HAEMATOLOGY
- Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis
- (2010) Sonia Chen et al. LARYNGOSCOPE
- Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
- (2010) Franck Lebrin et al. NATURE MEDICINE
- Heterogeneity of the Tumor Vasculature
- (2010) Janice Nagy et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Spontaneous Adult-Onset Pulmonary Arterial Hypertension Attributable to Increased Endothelial Oxidative Stress in a Murine Model of Hereditary Hemorrhagic Telangiectasia
- (2009) Mourad Toporsian et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells
- (2009) E. S. Shao et al. BLOOD
- Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
- (2009) Stella J. Bowcock et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hereditary haemorrhagic telangiectasia: a clinical and scientific review
- (2009) Fatima S Govani et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia
- (2009) Sung Ok Park et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia
- (2009) Jana Simonds et al. LARYNGOSCOPE
- Bevacizumab in Hereditary Hemorrhagic Telangiectasia
- (2009) Prithviraj Bose et al. NEW ENGLAND JOURNAL OF MEDICINE
- More on Bevacizumab in Hereditary Hemorrhagic Telangiectasia
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis
- (2009) Helia B. Schonthaler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia
- (2008) Andrew Mitchell et al. LIVER TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search